SLC38A1 and neoplasm: Two other glutamine transporters, SNAT1 and SNAT2, were induced to compensate for glutamine uptake.18,19 Therefore, targeting ASCT2, SNAT1 and SNAT2 together should be evaluated for their tumour suppression capability.